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A B S T R A C T
The purpose of the present study was to investigate polymorphism of HLA class II
haplotypic associations (HLA-DRB1, -DQA1, -DQB1) and DQCAR alleles in 78 Cro-
atian patients with psoriasis. Patients were divided into two groups according to a fam-
ily history of disease and age of onset: type I (positive family history and early onset)
and type II (negative family history and late onset). The difference in frequency of HLA
class II haplotypic associations between type I patients and controls was observed for
the following combinations: HLA-DRB1*0701, -DQA1*0201, -DQB1*02 (23.6% vs. 7.2%;
p < 0.001), HLA-DRB1*0701, -DQA1*0201, -DQB1*0303 (8.5% vs. 1.3%; p = 0.0018) and
HLA-DRB1*1601, -DQA1*0102, -DQB1*0502 (2.8% vs. 9.3%; p = 0.06). The difference
between type II psoriasis and controls for association: HLA-DRB1*1501, -DQA1*0102,
-DQB1*0602 is not significant (20.0% vs. 8.9%; p = 0.06). The significantly higher fre-
quency of DQCAR 113bp and 119bp alleles in patients with type I psoriasis is a result of
linkage disequlibrium of these alleles with both HLA-DRB1*0701 haplotypic associa-
tions. Analysis of DQCAR alleles in the HLA-DRB1*0701 haplotypic associations in pa-
tients with psoriasis vulgaris and matched controls did not reveal any difference in
polymorphism of DQCAR alleles. These data suggest that HLA-DRB*0701 haplotypic
combinations are associated with type I but not for type II psoriasis in the Croatian po-
pulation. DQCAR polymorphism is not useful genetic marker to distinguish susceptible
HLA class II haplotypic association.
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Introduction
Psoriasis vulgaris (PV) is a chronic hy-
perproliferative inflammatory skin dise-
ase affecting about 2% Caucasians1. The
etiology of psoriasis has remained un-
clear, but genetic2, immunological3 and
environmental factors are suggested to
play important roles in the pathogenesis
of PV. Numerous serologically defined
studies showed that HLA-B13, B17, B27,
B39, Cw2, Cw6, Cw7, and DR7 are risk
HLA antigens for psoriasis4. The associa-
tion between psoriasis and HLA antigens
supports the concept of psoriasis being a
T cell-mediated autoimmune disease. On
the basis of these associations two types
of psoriasis vulgaris can be differenti-
ated: i) type I, manifesting early in life
and frequently affecting other family mem-
bers, is associated with HLA-B13, B17,
B39 and DR7; ii) type II, having a late on-
set and not affecting other family mem-
bers, is associated weakly with HLA-B27,
and Cw25. The largest and most consis-
tently reported relative risk of developing
psoriasis has been its association with
Cw6 and DR76,7.
Molecular studies have reported about
association between HLA-DRB1*07-DQA
*0201-DQB1*0303 and psoriasis vulga-
ris8,9. The use of HLA genes as only ge-
netic markers in studies of disease associ-
ation with HLA is not ideal because of
well known linkage disequlibrium between
alleles of different loci10. So, additional
genetic markers within HLA region are
needed for the better characterization of
association between HLA genes and dis-
ease. Such additional markers are mi-
crosatellite loci within the HLA region11,12.
Studies using microsatellites located in
the HLA region show how to better locate
a disease susceptibility gene, or how to
determine more precisely numerous mar-
kers involved in the genetic susceptibi-
lity13–15. For example, it is well known
that many autoimmune diseases are HLA
-DR and -DQ associated. In some cases is
not possible to establish whether the pri-
mary association is to DR or DQ alleles,
or influenced by some other polymor-
phisms in the DR-DQ region. To help re-
solve such kind of problems microsatelli-
tes located in that small region between
DR-DQ loci can better explain association
between disease and DR or DQ alleles.
The role of microsatellite markers within
HLA region for the analysis of linkage
disequlibrium with HLA alleles has re-
cently become of great importance in stu-
dies of HLA-associated diseases, includ-
ing insulin-dependent diabetes mellitus
(IDDM)16, celiac disease (CD)16, idiopathic
nephrotic syndrome (INS)16, rheumatoid
arthritis (RA)17, hemochromatosis17. In the
present study, we analyzed HLA-DRB1,
-DQA1, -DQB1 haplotypic associations
and the frequency of DQCAR microsa-
tellite polymorphism in a population of




Seventy-eight patients with chronic
stable psoriasis from the Department of
Dermatology, University of Rijeka, Cro-
atia, were assigned to either type I or
type II psoriasis. Fifty-three patients with
positive family history and age of onset
less than 30 years were grouped to type I
psoriasis9, while 25 patients with a nega-
tive family history and age of onset later
than 40 years were grouped to type II
psoriasis9. Two control groups were used:
i) C1 group for HLA class II haplotypic as-
sociation study was composed of 135 heal-
thy unrelated donors from the wider area
of the Croatian capital city, Zagreb; ii) C2
group for studying DRB1*07 positive ha-
plotypic associations was formed of 44 in-
dividuals undergoing paternity testing
who were positive for DRB1*07 allele.
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Methods
DNA was prepared from peripheral
blood lymphocytes using standard salting
out protocol18. Controls and patients were
typed for HLA class II alleles by a high-
-resolution polymerase chain reaction
(PCR) with sequence-specific oligo probes
(PCR-SSOP) method, as described by Ki-
mura et al.19. PCR amplification was per-
formed with a set of specific primers for
the second exons of DRB1, DQA1 and
DQB1 genes as described elsewhere. PCR
products were blotted on nylon membra-
nes, and hybridized with biotinylated pro-
bes, as specified at the 12th International
Histocompatibility Workshop (IHW)20.
Forty-two DRB1 alleles, 8 DQA1 alleles,
and 13 DQB1 alleles were tested, repre-
senting the most common Caucasoid HLA
class II alleles.
Amplification of DQCAR microsatel-
lite locus was performed as previously
described21. The forward primer was la-
beled at the 5' end with Cyp5, and reverse
primer was not labeled22. After the ampli-
fication, samples were run on a standard
denaturing sequencing gel (6.0% poly-
acrilamide) in an Automated Laser Fluo-
rescence DNA sequencer (ALF express,
Pharmacia Biotech, Uppsala, Sweden).
The data were analyzed by the Fragment
Manager software (Pharmacia).
The frequencies of HLA-DRB1, -DQA1,
-DQB1, and DQCAR alleles and haplo-
typic associations were estimated by the
direct counting. The HLA class II ha-
plotypes were assigned on the basis of
known linkage disequilibrium as described
in previous studies23,24. It was presumed
that the DRB1, DQA1, DQB1, and DQCAR
loci have no blanks and based on this pre-
sumption, when a single HLA class II al-
lele or DQCAR allele was observed, the
individual was considered as homozygous
for that allele. The significance of differ-
ences in haplotypic association frequen-
cies was evaluated using chi-square while
Fisher's exact test was used if any value
in a 2x2 table was lower than five25. Rela-
tive risk (RR) was calculated according to
Woolf26.
Results
The distribution of HLA class II
haplotypic associations
Seventy-eight psoriatic patients were
tested for HLA-DRB1, -DQA1, -DQB1 ha-
plotypic associations (Table 1). Seventeen
different HLA class II haplotypic associa-
tions could be identified in a sample of 58
patients with type I psoriasis, while 12
distinct combinations of HLA class II al-
leles were found in a sample of 25 pa-
tients with type II psoriasis. In the group
of type I psoriatic patients, the associa-
tion most frequently detected was HLA
-DRB1*0701, -DQA1*0201, -DQB1*02. This
association was present in 22 (41.5%) pa-
tients with type I psoriasis; three of them
were homozygous for this haplotypic com-
bination. In contrast, only four (16.0%)
type II psoriatic patients were positive for
this association. Among control individu-
als only 19 out of 118 individuals were
positive for this association. At the chro-
mosomal level, the numbers were 25
(23.6%) in type I and 4 (8.0%) in type II
psoriasis, compared to 7.2% in the control
population. This difference in frequency
is statistically significant (p < 0.001). The
HLA-DRB1*0701, -DQA1*0201, -DQB1
*0303 haplotypic association was found
in 9 patients with type I disease, while
among 25 type II psoriatic patients this
association was not observed. Compari-
son of frequency of this association be-
tween type I psoriatic patients and con-
trols revealed statistically significant dif-
ference (8.5% vs. 1.3; p = 0.0018).
Some haplotypic associations, e.g.,
HLA-DRB1*1501, -DQA1*0102, -DQB1
*0602, HLA-DRB1*1101, -DQA1*0501,
-DQB1*0301, and HLA-DRB1*1302, -DQA1
*0102, -DQB1*0604, were found to be con-
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siderably more frequent in type II com-
pared to type I psoriasis. The difference
in distribution of HLA-DRB1*1101, -DQA1
*0501, -DQB1*0301 haplotypic associa-
tion is not significant (p > 0.05), while
HLA-DRB1*1501, -DQA1*0102, -DQB1
*0602 association showed marginally sig-
nificant p value (p = 0.06). In the case of
HLA-DRB1*1302, -DQA1*0102, -DQB1
*0604 the p value was significant (p =
0.034).
The distribution of DQCAR alleles
Nine different DQCAR alleles were
detected in our patients (Table 2). The
statistically significant differences were
detected for DQCAR 113bp allele in type I
psoriasis in comparison to controls (15.1%
vs. 3.3%; p < 0.001), as well as for DQCAR
119bp allele (12.3 vs. 5.6%; p = 0.036).
DQCAR 107bp allele was less present in
type I psoriasis than in controls (2.8% vs.
11.9%; p = 0.006). Comparison of DQCAR
allele frequencies between two patient
groups showed difference only for DQCAR
113bp allele, but without statistically sig-
nificant p value (15.1% vs. 6.0%; p = 0.08).
Discussion
Our data on distribution of HLA class
II haplotypic associations in a sample of
87 Croatian psoriatic patients confirmed
statistically significant higher frequency
of HLA-DRB1*0701, -DQA1*0201, -DQB1
*02 haplotypic association in type I pso-
riatic patients, as well as haplotypic asso-
ciation HLA-DRB1*0701, -DQA1*0201,
-DQB1*0303. This is in concordance with
the results obtained for patients from
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TABLE 1
THE DISTRIBUTION (NO, %) OF HLA-DRB1, -DQA1, -DQB1 HAPLOTYPIC ASSOCIATIONS IN
CROATIAN PATIENTS WITH TYPE I OR TYPE II PSORIASIS AND CONTROL INDIVIDUALS
Haplotypic association (allele) No. (%) of patients with psoriasis No. (%) of con-
trols (N=118)DRB1 DQA1 DQB1 Type I (N=53) Type II (N=25)
0101 0101 0501 12 (11.3) 6 (12.0) 21 (8.9)
1501 0102 0602 7 (6.6) 10 (20.0) 21 (8.9)
1501 0102 0502 1 (0.9) 1 (2.0) 1 (0.4)
1601 0102 0502 3 (2.8) 3 (6.0) 22 (9.3)
1602 0102 0502 1 (0.9) 0 3 (1.3)
0301 0501 0201 6 (5.7) 4 (8.0) 18 (7.6)
04 0301 0302 8 (7.5) 4 (8.0) 16 (6.8)
1101 0501 0301 6 (5.7) 6 (12.0) 16 (6.8)
1104 0501 0301 7 (6.6) 3 (6.0) 18 (7.6)
1301 0102 0604 6 (5.7) 3 (6.0) 13 (5.5)
1302 0102 0604 1 (0.9) 4 (8.0)* 7 (3.0)
1303 0501 0301 3 (2.7) 0 3 (1.3)
1401 0101 0503 1 (0.9) 2 (4.0) 8 (3.4)
0701 0201 02 25 (23.6)*** 4 (8.0) 17 (7.2)
0701 0201 0303 9 (8.5)** 0 3 (1.3)
08 0401 0401 5 (4.7) 0 2 (0.9)
1001 0101 0501 5 (4.7) 0 5 (2.1)
x x x 42 (17.8)
***p<0.001; **p<0.01; *p<0.05;
x = different DRB1-DQA1-DQB1 haplotypic associations not observed in patients with psoriasis
Germany9 where the association between
psoriasis and both DRB1*0701 haploty-
pic associations were found. We calcu-
lated relative risks for those two haplo-
typic associations as follows: RR = 4.65
for association HLA-DRB1*0701, -DQA1
*0201, -DQB1*02 and RR = 7.84 for com-
bination HLA-DRB1*0701, -DQA1*0201,
-DQB1*0303.
To define the existence of an addi-
tional genetic marker in the region be-
tween DR and DQ genes, which would be
helpful to distinguish susceptible from
not-susceptible haplotypic association,
we have characterized DQCAR polymor-
phism in DRB1*0701 haplotypic associa-
tions in two groups of psoriatic patients,
as well as in healthy controls. Namely, re-
sults of our previous population study
about DQCAR polymorphism showed that
HLA-DRB1*0701, -DQA1*0201, -DQB1
*0201 haplotypic association is not exclu-
sively associated with one DQCAR allele
as was observed for some of the other
associations22. has the greatest DQCAR
polymorphism22. We found 6 different
DQCAR alleles (DQCAR 111bp, 113bp,
117bp, 119bp, or 121bp) in combination
with HLA-DRB1*0701, -DQA1*0201,
-DQB1*0201 haplotypic association. These
alleles were present with a similar fre-
quency in a sample of 30 unrelated HLA
matched controls, 25 patients with type I
psoriasis and 4 patients with type II (Ta-
ble 3). On the basis of results listed in Ta-
ble 3 we can only speculate about protec-
tive role of DQCAR 117bp allele in type II
psoriasis, because this allele was not pre-
sent among patients with this type of dis-
ease, but it is necessary to confirm on a
bigger sample of patients. However, our
findings of significant differences in dis-
tribution of DQCAR 113bp and DQCAR
119bp alleles between patients and con-
trols are results of linkage disequilibrium
between DQCAR alleles and HLA-DRB1
*0701 haplotypic associations27,28. It sug-
gests that DR genes themselves are pri-
mary involved in the pathophysiology of
psoriasis what is in concordance with da-
ta from Kwok et al.29. Similar findings
are reported for some other autoimmune
diseases (celiac disease, insulin depend-
ent diabetes mellitus)16.
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TABLE 2
COMPARISON OF DQCAR ALLELE FREQUENCIES (NO, %) IN A SAMPLE OF CROATIAN PATIENTS
WITH PSORIASIS (N=78) AND A SAMPLE OF UNRELATED CROATIANS (N=118)
No. (%) of patients with psoriasis No. (%) of controls
DQCAR allele Type I (N=53) Type II (N=25) (N=118)
99bp 8 (7.5) 6 (12.0) 25 (10.7)
101bp 0 0 0
103bp 32 (30.2) 22 (44.0) 86 (36.4)
105bp 5 (4.7) 2 (4.0) 1 (0.3)
107bp 3 (2.8)** 4 (8.0) 28 (11.9)
109bp 0 0 1 (0.3)
111bp 7 (6.6) 5 (10.0) 28 (11.9)
113bp 16 (15.1)*** 3 (6.0) 8 (3.3)
115bp 0 0 0
117bp 6 (5.7) 0 14 (5.9)
119bp 13 (12.3)* 3 (6.0) 13 (5.6)
121bp 15 (14.1) 5 (10.0) 32 (13.7)
***p<0.001; **p<0.01; *p<0.05
In conclusion, the strongest correla-
tion in the Croatian population exists be-
tween HLA-DRB1*0701, -DQA1*0201,
-DQB1*02 haplotypic association and type
I but not with type II disease. DQCAR
polymorphism is not useful additional ge-
netic marker for distinguishing disease
associated DRB1*0701 haplotypic associ-
ation. Our findings of association
between psoriasis and HLA class II mole-
cules further support the concept of type I
psoriasis being a T-cell-mediated autoim-
mune disease28.
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TABLE 3
THE DISTRIBUTION (NO, %) OF DQCAR ALLELES ON HLA-DRB1*0701, -DQA1*0201, -DQB1*02
HAPLOTYPIC ASSOCIATIONS IN A SAMPLE OF CROATIAN PATIENTS WITH TYPE I (N=25) AND
TYPE II PSORIASIS (N=4) AND HLA MATCHED CONTROLS (N=30)a
No. (%) of patients with psoriasis No. (%) of controls
DQCAR allele Type I (N=25) Type II (N=4) (N=30)
111bp 3 (12.0) - -
113bp 15 (60.0) 3 (75.0) 18 (60.0)
117bp – – 3 (10.0)
119bp 3 (12.0) 1 (25.0) 5 (16.7)
121bp 4 (16.0) – 4 (13.3)
a controls are positive for HLA-DRB1*0701-DQA1*0201-DQB1*02 haplotypic associations
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RAZNOVRSNOST HAPLOTIPSKIH VEZA HLA RAZREDA II (HLA-DRB1,
-DQA1, -DQB1) I ALELA LOKUSA DQCAR U BOLESNIKA S PSORIJAZOM
U HRVATSKOJ
S A @ E T A K
Cilj rada bio je ispitati raznovrsnost haplotipskih veza HLA razreda II (HLA
-DRB1, -DQA1, -DQB1) i alela lokusa DQCAR u skupini od 78 bolesnika s psorijazom.
Bolesnici su bili podijeljeni u dvije skupine obzirom na obiteljsku anamnezu, kao i na
vrijeme pojave bolesti: tip I (pozitivna obiteljska anamneza i rana pojava psorijaze) i
tip II (negativna obiteljska anamneza i kasnija pojava psorijaze). Razlike u raspodjeli
haplotipskih veza izme|u bolesnika s tipom I psorijaze uo~ene su za slijede}e veze:
HLA-DRB1*0701, -DQA1*0201, -DQB1*02 (23.6% vs. 7.2%; p < 0.001), HLA-DRB1*0701,
-DQA1*0201, .DQB1*0303 (8.5% vs. 1.3%; p = 0.0018) i HLA-DRB1*1601, -DQA1*0102,
-DQB1*0502 (2.8% vs. 9.3%; p = 0.06). Uo~ena razlika u raspodjeli haplotipske veze
HLA-DRB1*1501, -DQA1*0102, -DQB1*0602 izme|u skupine bolesnika s tipom II
psorijaze i kontrole nije statisti~ki zna~ajna (20.0% vs. 8.9%; p = 0.06). Statisti~ki zna-
~ajno povi{ena u~estalost alela DQCAR 113bp i 119bp posljedica je neravnote`e udru`i-
vanja tih alela s obje HLA-DRB1*0701 haplotipske veze. Analiza raznovrsnosti DQCAR
alela unutar HLA-DRB1*0701 haplotipskih veza nije pokazala nikakvu razliku izme-
|u bolesni~ke i kontrolne skupine. Na{i rezultati ukazuju da su obje HLA-DRB1*0701
haplotipske veze u Hrvatskoj povezane s tipom I psorijaze, ali ne i s tipom II.
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